NIOX Group (LON:NIOX) Shares Down 2.3% – Here’s Why

NIOX Group Plc (LON:NIOX)’s stock price dropped 2.3% during trading on Wednesday . The company traded as low as GBX 59 ($0.73) and last traded at GBX 60 ($0.74). Approximately 260,541 shares traded hands during trading, a decline of 32% from the average daily volume of 384,684 shares. The stock had previously closed at GBX 61.40 ($0.76).

NIOX Group Stock Down 2.3 %

The stock has a market cap of £254.48 million, a price-to-earnings ratio of 3,000.00 and a beta of 0.92. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.94 and a current ratio of 6.32. The firm’s 50-day simple moving average is GBX 62.85 and its two-hundred day simple moving average is GBX 64.94.

Insider Activity at NIOX Group

In related news, insider Garry Watts sold 27,109 shares of the firm’s stock in a transaction dated Friday, October 25th. The stock was sold at an average price of GBX 80 ($0.99), for a total value of £21,687.20 ($26,807.42). Also, insider Jonathan Emms acquired 31,604 shares of the company’s stock in a transaction on Wednesday, December 18th. The shares were purchased at an average cost of GBX 63 ($0.78) per share, with a total value of £19,910.52 ($24,611.27). 46.72% of the stock is currently owned by company insiders.

NIOX Group Company Profile

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.